E-LIB Suche - Ergebnisse für: Denisova, Oxana V

1

PP2A‐based triple‐strike therapy overcomes mitochondrial ap..:

Denisova, Oxana V. ; Merisaari, Joni ; Huhtaniemi, Riikka...
Molecular Oncology. 17 (2023) 9 - p. 1803-1820 , 2023

Link: https://doi.org/10.1002/..

2

Development of actionable targets of multi-kinase inhibitor..:

Denisova, Oxana V. ; Merisaari, Joni ; Kaur, Amanpreet...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

3

Monotherapy efficacy of blood–brain barrier permeable small..:

Merisaari, Joni ; Denisova, Oxana V ; Doroszko, Milena...
Brain Communications. 2 (2020) 1 - p. , 2020

Link: https://doi.org/10.1093/..

4

Phosphoproteomics to Characterize Host Response During Infl..:

Söderholm, Sandra ; Kainov, Denis E. ; Öhman, Tiina...
Molecular & Cellular Proteomics. 15 (2016) 10 - p. 3203-3219 , 2016

Link: https://doi.org/10.1074/..

5

Inhibition of Influenza A Virus Infection in Vitro by Salip..:

Bimbo, Luis M. ; Denisova, Oxana V. ; Mäkilä, Ermei...
ACS Nano. 7 (2013) 8 - p. 6884-6893 , 2013

Link: https://doi.org/10.1021/..

6

Obatoclax, Saliphenylhalamide, and Gemcitabine Inhibit Infl..:

Denisova, Oxana V. ; Kakkola, Laura ; Feng, Lin...
Journal of Biological Chemistry. 287 (2012) 42 - p. 35324-35332 , 2012

Link: https://doi.org/10.1074/..

7

PP2A‐based triple‐strike therapy overcomes mitochondrial ap..:

Denisova, Oxana V ; Merisaari, Joni ; Huhtaniemi, Riikka...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483611/. , 2023

Link: http://www.ncbi.nlm.nih...

8

PP2A ‐based triple‐strike therapy overcomes mitochondrial a..:

Denisova, Oxana V ; Merisaari, Joni ; Huhtaniemi, Riikka...
https://resolver.sub.uni-goettingen.de/purl?gro-2/131992. , 2023

Link: https://resolver.sub.uni..

9

PP2A-based triple-strike therapy overcomes mitochondrial ap..:

Denisova, Oxana V ; Merisaari, Joni ; Huhtaniemi, Riikka...
Denisova, Oxana V. Merisaari, Joni Huhtaniemi, Riikka Qiao, Xi Yetukuri, Laxman Jumppanen, Mikael Kaur, Amanpreet Pääkkönen, Mirva von Schantz-Fant, Сarina Ohlmeyer, Michael Wennerberg, Krister Kauko, Otto Koch, Raphael Aittokallio, Tero Antero Taipale, Mikko Westermarck, Jukka . PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. Molecular Oncology. 2023, 17(9), 1803-1820. , 2023

Link: http://hdl.handle.net/10..

10

PP2A-based triple-strike therapy overcomes mitochondrial ap..:

Denisova, Oxana V ; Merisaari, Joni ; Huhtaniemi, Riikka...
10.1002/1878-0261.13488. , 2023

Link: http://hdl.handle.net/10..

11

Development of actionable targets of multi-kinase inhibitor..:

Denisova, Oxana V ; Merisaari, Joni ; Kaur, Amanpreet...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376105/. , 2022

Link: http://www.ncbi.nlm.nih...

12

Monotherapy efficacy of blood–brain barrier permeable small..:

Merisaari, Joni ; Denisova, Oxana V ; Doroszko, Milena...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425423/. , 2020

Link: http://www.ncbi.nlm.nih...

13

Monotherapy efficacy of blood-brain barrier permeable small..:

Merisaari, Joni ; Denisova, Oxana, V ; Doroszko, Milena...
Brain Communications, 2020, 2:1,. , 2020

Link: http://urn.kb.se/resolve..

14

Phosphoproteomics to Characterize Host Response During Infl..:

Söderholm, Sandra ; Kainov, Denis E ; Öhman, Tiina...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054344/. , 2016

Link: http://www.ncbi.nlm.nih...

15

Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infecti..:

Denisova, Oxana V ; Söderholm, Sandra ; Virtanen, Salla...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC. , 2014

Link: http://www.ncbi.nlm.nih...